Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AAC Clyde Space | MKC0 | Sep 20, 2024 | 3.02 | -0.17 |
AAC TECH | A2XN | Sep 20, 2024 | 3.18 | -3.05 |
Aadi Bioscience | 3350 | Sep 20, 2024 | 1.60 | -3.03 |
AAK | 6AA0 | Sep 20, 2024 | 28.76 | +1.34 |
Aalberts NV | AACA | Sep 20, 2024 | 34.88 | +0.58 |
Aallon Group | I74 | Sep 20, 2024 | 8.30 | -0.72 |
AAP Implantate AG | AAQ1 | Sep 20, 2024 | 1.12 | +0.90 |
AAR Corp. | ARZ | Sep 20, 2024 | 61.65 | +0.08 |
AB Akola Group | YG4 | Sep 20, 2024 | 1.10 | +1.39 |
AB Amber Grid | AMH | Sep 20, 2024 | 1.07 | -0.93 |
AB Dynamics plc | 6DY | Sep 20, 2024 | 23.00 | +3.60 |
AB Ignitis Grupe | IGV0 | Sep 20, 2024 | 18.76 | -4.19 |
AB S.A. | 8B6 | Sep 20, 2024 | 21.40 | +4.39 |
Ab Science | A8D | Sep 20, 2024 | 0.99 | +1.75 |
ABACUS GRP UTS | EZO1 | Sep 20, 2024 | 0.81 | +1.43 |
Abacus Mining & Exploration Corp. | DGV2 | Sep 20, 2024 | 0.01 | 0.00 |
ABB Ltd | ABJA | Sep 20, 2024 | 50.50 | +1.00 |
Abbott Laboratories | ABL | Sep 20, 2024 | 102.72 | -1.15 |
AbbVie Inc. | 4AB | Sep 20, 2024 | 173.06 | -0.25 |
ABC | EK7 | Sep 20, 2024 | 0.38 | -12.75 |
ABC Arbitrage | 9BA | Sep 20, 2024 | 4.45 | +0.45 |
ABC-Mart Inc. | 5B8 | Sep 20, 2024 | 18.30 | -0.54 |
AbCellera Biologics Inc. - | 8QQ | Sep 20, 2024 | 2.33 | -6.23 |
Abcourt Mines, Inc. | AML | Sep 20, 2024 | 0.03 | +12.24 |
ABEN MINERALS LTD | R26 | Sep 20, 2024 | 0.03 | -9.38 |
Abercrombie & Fitch Company | AFT | Sep 20, 2024 | 127.50 | +3.11 |
Aberdeen Asia-Pacific Income Fund Inc | 9J9 | Sep 20, 2024 | 2.40 | 0.00 |
Aberdeen Asia-Pacificome Fund | 9J90 | 0.00 | 0.00 | |
Aberdeen International Inc | A8H | Sep 20, 2024 | 0.01 | -31.58 |
Aberdeen Standard European Logistics Income Plc | 5JX | Sep 20, 2024 | 0.70 | -2.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.